Search Results 1461-1470 of 21851 for IBD

  1. Crohn's disease - Doctors and departments - Mayo Clinic

    Inflammatory Bowel Disease Clinic · Laboratory Medicine and Pathology · Pediatric Surgery · Radiology. Areas that research this condition. Radiology Research ...

  2. Crohn's disease - Doctors and departments - Mayo Clinic

    Inflammatory Bowel Disease Clinic · Laboratory Medicine and Pathology · Pediatric Surgery · Radiology. Areas that research this condition. Radiology Research ...

  3. Colon cancer - Doctors and departments - Mayo Clinic

    ... Inflammatory bowel disease, Crohn's disease, Colon cancer, Rectal cancer, Familial adenomatous polyposis, Colon polyps, Anal cancer, Hemorrhoids, Anal ...

  4. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    Surgical intervention for IBD during or after participation in Study MLN0002SC-3027 or MLN0002SC-3031, or at any time during this study. Chronic or severe ...

  5. A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis - Mayo Clinic

    Current moderate to severely active inflammatory bowel disease (IBD). Note: Other protocol defined Inclusion/Exclusion criteria may apply. Participating ...

  6. Colon cancer - Doctors and departments - Mayo Clinic

    ... Inflammatory bowel disease, Crohn's disease, Colon cancer, Rectal cancer, Familial adenomatous polyposis, Colon polyps, Anal cancer, Hemorrhoids, Anal ...

  7. Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome - Mayo Clinic

    Known diagnosis of inflammatory bowel disease, microscopic colitis, celiac disease or other inflammatory condition; Antibiotic use within the past 4 weeks ...

  8. Colonoscopy - Doctors & Departments - Mayo Clinic

    Inflammatory bowel disease (IBD) · Intestinal ischemia · Iron deficiency anemia · Irritable bowel syndrome · Ischemic colitis · Mayo Clinic Minute: What you ...

  9. Mayo Clinic in Arizona Part of Study to Help Regulate Immune System

    Leighton says, "From a clinical standpoint, we think that three factors predispose to inflammatory bowel disease – genetics, environment and the immune system.

  10. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Poorly controlled inflammatory bowel disease (IBD) that is moderately or severely active or having a fistula interfering with the trial assessments;; Bowel ...